Gilead Has Paid $178 Million to Doctors to Promote Drugs Despite Patient Deaths

Dilyana Gaytandzhieva

American pharmaceutical giant Gilead has paid at least $178 million to doctors and $81 million to hospitals in the US to promote and prescribe the company’s drugs despite cases of deaths and severe side effects. The drug-maker funded as many as 21,833 physicians in 2019 alone, according to data about Gilead payments from 2013 to 2019.

Deaths of patients in treatment with the Gilead hepatitis C antiviral Harvoni have been reported in the US, Canada, and Portugal, according to data obtained from the US Federal Drug Administration (FDA).

Despite the severe side effects from these Gilead hepatitis C antivirals the pharmaceutical company has listed none of them so that patients can make their informed decision.

Instead, Gilead has paid kickbacks to doctors to prescribe these drugs without patients being informed about the possible risks.

Latest articles

Rebecca Park Totilo Essential Oils for radiation sickness, biological warfare, chemical warfare...
Rebecca Park Totilo Living Grand Convention that inflammation is a signal that...
Maharishi Ayurveda Products International, Inc. Radiation—energy that travels through the atmosphere as...
Alan V. Schmukler There are numerous substances which are rumored to offer...
World Health Organization This document describes protocols and practices for ensuring the...

Thank you!

Thank you for your membership application. As soon as your payment has been received your membership will be activated and you will be informed via email.

Thank you.

Thank you!

The form has been submitted successfully!